N. Bulieva

The results of the use of Octofactor in patients with moderate and severe hemophilia A (data from a prospective, multicenter, open-label, observational study)

S. Morozov, E. Schiller, N. Zozulya, 2019, Russian Journal of Pediatric Hematology and Oncology.

[Five year experience in ibrutinib therapy for relapsed and refractory mantle cell lymphoma in real world Russian clinical practice].

N. Mikhailova, V. A. Zherebtsova, O. Margolin, 2021, Terapevticheskii arkhiv.